Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
Clinical trial NCT04492475 · COMPLETED
Trial details
- NCT number
- NCT04492475
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2020-12-21
- Enrollment
- 969
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.